Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis

Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China

(2015) Mao-Sheng Ran et al.   BRITISH JOURNAL OF PSYCHIATRY

Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study

(2015) Vincent Chin-Hung Chen et al.   SCHIZOPHRENIA RESEARCH

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Premature Mortality Among Adults With Schizophrenia in the United States

(2015) Mark Olfson et al.   JAMA Psychiatry

Mortality in Mental Disorders and Global Disease Burden Implications

(2015) Elizabeth Reisinger Walker et al.   JAMA Psychiatry

Amisulpride for Older Patients With Long-Standing Schizophrenia

(2014) Shani Pridan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Antipsychotic Treatment and Mortality in Schizophrenia

(2014) M. Torniainen et al.   SCHIZOPHRENIA BULLETIN

The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders

(2014) R. D. Hayes et al.   SCHIZOPHRENIA BULLETIN

Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials

(2013) Arif Khan et al.   JAMA Psychiatry

Guideline-Concordant Antipsychotic Use and Mortality in Schizophrenia

(2012) B. A. Cullen et al.   SCHIZOPHRENIA BULLETIN

Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial

(2011) Ragy R. Girgis et al.   BRITISH JOURNAL OF PSYCHIATRY

Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

(2011) Rosario de Arce Cordón et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

All-Cause Mortality and Medication Risk Factors in Schizophrenia

(2011) Diederik Tenback et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

(2010) S. H. L. Thomas et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine

(2010) Deanna L. Kelly et al.   JOURNAL OF CLINICAL PSYCHIATRY

Review: Mortality in schizophrenia: a measurable clinical endpoint

(2010) Chris J Bushe et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

(2010) Wolfgang Gaebel et al.   NEUROPSYCHOPHARMACOLOGY

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

(2010) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future

(2010) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization

(2009) Laurel A Copeland et al.   BMC HEALTH SERVICES RESEARCH

Reasons for discontinuing clozapine: matched, case–control comparison with risperidone long-acting injection

(2009) David M. Taylor et al.   BRITISH JOURNAL OF PSYCHIATRY

The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment

(2009) Siegfried Kasper et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration

(2009) C. W. Ritchie et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Influence of antipsychotics on mortality in schizophrenia: Systematic review

(2009) Stefan Weinmann et al.   SCHIZOPHRENIA RESEARCH

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia

(2008) Jari Haukka et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY